Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference59 articles.
1. Wouters OJ, McKee M, Luyten J. Estimated Research and Development investment needed to bring a new medicine to market, 2009-2018. JAMA. 2020;323(9):844–53. https://doi.org/10.1001/jama.2020.1166.
2. Brown DG, Wobst HJ, Kapoor A, Kenna LA, Southall N. Clinical development times for innovative drugs. Nat Rev Drug Discov. 2021. https://doi.org/10.1038/d41573-021-00190-9.
3. PDUFA reauthorization performance goals and procedures for fiscal years 2018 through 2022. https://www.fda.gov/media/99140/download, Accessed 12/11/2021.
4. Dose-Response information to support drug registration - Guidance for industry (1996). https://www.fda.gov/media/71279/download, Accessed 12/10/2021.
5. Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, Hu C, et al. Population pharmacokinetics. A regulatory perspective Clin Pharmacokinet. 1999 Jul;37(1):41–58. https://doi.org/10.2165/00003088-199937010-00003.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献